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CORRECTION
Src-Like Adaptor Protein (SLAP) differentially regulates normal
and oncogenic c-Kit signaling
Julhash U. Kazi, Shruti Agarwal, Jianmin Sun, Enrico Bracco and Lars Ro¨nnstrand
There was an error published in J. Cell Sci. 127, 653–662.
The second panel of Fig. 1I was supposed to show immunoblotting of immunoprecipitated FLAG-tagged SLAP but, unfortunately,
showed immunoblotting of whole-cell lysate (identical to the blot in the fifth panel of the figure). This has now been corrected so that the
third panel shows immunoblotting of immunoprecipitated FLAG-tagged SLAP as indicated.
The authors apologise for this mistake.
 2014. Published by The Company of Biologists Ltd | Journal of Cell Science (2014) 127, 2376 doi:10.1242/jcs.155150
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Src-like-adaptor protein (SLAP) differentially regulates normal and
oncogenic c-Kit signaling
Julhash U. Kazi1, Shruti Agarwal1, Jianmin Sun1, Enrico Bracco2 and Lars Ro¨nnstrand1,*
ABSTRACT
The Src-like-adaptor protein (SLAP) is an adaptor protein sharing
considerable structural homology with Src. SLAP is expressed in a
variety of cells and regulates receptor tyrosine kinase signaling by
direct association. In this report, we show that SLAP associates with
both wild-type and oncogenic c-Kit (c-Kit-D816V). The association
involves the SLAP SH2 domain and receptor phosphotyrosine
residues different from those mediating Src interaction. Association
of SLAP triggers c-Kit ubiquitylation which, in turn, is followed by
receptor degradation. Although SLAP depletion potentiates c-Kit
downstream signaling by stabilizing the receptor, it remains non-
functional in c-Kit-D816V signaling. Ligand-stimulated c-Kit or c-Kit-
D816V did not alter membrane localization of SLAP. Interestingly
oncogenic c-Kit-D816V, but not wild-type c-Kit, phosphorylates SLAP
on residues Y120, Y258 and Y273. Physical interaction between c-
Kit-D816V and SLAP is mandatory for the phosphorylation to take
place. Although tyrosine-phosphorylated SLAP does not affect c-Kit-
D816V signaling, mutation of these tyrosine sites to phenylalanine
can restore SLAP activity. Taken together the data demonstrate that
SLAP negatively regulates wild-type c-Kit signaling, but not its
oncogenic counterpart, indicating a possible mechanism by which
the oncogenic c-Kit bypasses the normal cellular negative feedback
control.
KEY WORDS: Kit, c-Kit-D816V, D816V, Receptor tyrosine kinase,
Signal transduction, SLA, Ubiquitylation
INTRODUCTION
The Src-like adaptor protein (SLAP) is an adaptor protein
containing both Src homology 2 (SH2) and SH3 domains. SLAP
displays considerable structural homology with Src but lacks its
kinase domain. Similar to Src, SLAP is myristoylated, thus it
localizes to the cell membrane (Manes et al., 2000). Furthermore,
the presence of an SH2 domain facilitates association of SLAP
with many receptors through phosphotyrosine residues and
thereby impairs Src-mediated signaling by competing with Src
itself.
SLAP is primarily implicated in negative regulation of receptor
signaling by facilitating the recruitment of E3 ubiquitin ligases.
Because SLAP is capable of association with E3 ubiquitin ligase
Cbl through its C-terminal tail in a phosphorylation-independent
manner, it can form multi-proteins complex (Tang et al., 1999).
The ability to self-dimerize also allows SLAP to recruit many
proteins at the same time (Tang et al., 1999).
Despite its role in negative regulation of receptor signaling,
SLAP is also capable of potentiating signals from certain receptors
through unknown mechanism. SLAP transduces mitogenic signals
from Syk to NAFT-AP1 and depletion of SLAP reduces FLT3
ligand-induced Akt and Erk1/2 phosphorylation (Kazi and
Ro¨nnstrand, 2012; Tang et al., 1999) suggesting that SLAP plays
differential roles depending on its kinase partner.
Type III receptor tyrosine kinase (RTK) c-Kit (also known as
Kit) is of importance in a variety of physiological conditions and is
frequently mutated in many cancers (Kazi et al., 2008; Lennartsson
and Ro¨nnstrand, 2012). Whereas wild-type c-Kit receptor requires
ligand stem cell factor (SCF) to trigger its dimerization and
activation, the oncogenic c-Kit mutants display ligand-independent
activation. One of the very first manifestations of an active c-Kit
receptor is auto-phosphorylation on multiple tyrosine residues.
These phosphotyrosine residues facilitate docking of multiple
SH2-domain-containing proteins which, in turn, further propagate
or counteract receptor signaling by distinct mechanisms (Masson
and Ro¨nnstrand, 2009). For example, association of Cbl through
Y568 directs c-Kit to lysosomal degradation (Masson et al., 2006),
whereas association of Src through the same tyrosine residue
potentiates downstream signaling (Lennartsson et al., 1999). Many
receptor-interacting proteins tightly regulate receptor stability,
phosphorylation and signaling by linking kinases, ubiquitin ligases
and other signaling molecules (Kazi and Ro¨nnstrand, 2013a; Kazi
and Ro¨nnstrand, 2013b; Kazi et al., 2012; Kazi et al., 2013b; Lin
et al., 2012).
Here, we show that SLAP associates with both normal and
oncogenic mutants of c-Kit and that these associations have
differential impacts on receptor downstream signaling.
RESULTS
SLAP associates with SCF-stimulated wild-type c-Kit as well as with
oncogenic c-Kit-D816V
There is increasing evidence that SLAP regulates receptor
signaling. We and other groups recently showed that SLAP
associates with a variety of receptors including EphA (Semerdjieva
et al., 2013) and FLT3 (Kazi and Ro¨nnstrand, 2012) in a
phosphorylation-dependent manner. FLT3 is a type III RTK that
is found to be frequently mutated in hematopoietic malignancies
(Kabir et al., 2013). In our previous report we also showed that
SLAP is highly expressed in hematopoietic cells. Since c-Kit
belongs to the same RTK family as FLT3 and is highly expressed
in hematopoietic malignancies, we tested whether SLAP
correspondingly associates with c-Kit. We co-transfected FLAG-
tagged SLAP with wild-type c-Kit or an oncogenic version with an
aspartic acid to valine mutation (c-Kit-D816V). We were only able
to pull down c-Kit with an anti-FLAG antibody from cells that
were stimulated with SCF prior to lysis (Fig. 1A, lane 3). The
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oncogenic c-Kit-D816Vmutant is characterized by constitutive tyrosine
kinase activity. In the case of the c-Kit-D816V mutant, a strong ligand-
independent interaction between SLAP and c-Kit-D816V was detected
(Fig. 1A, lane 4). These data suggest that SLAP associates with c-
Kit only when c-Kit is tyrosine phosphorylated. The efficiency of
c-Kit pull-down from cell lysates was independent of c-Kit
Fig. 1. SLAP associates with c-Kit-WTand c-Kit-D816V through the SLAPSH2 domain. (A) COS-1 cells were transfected with SLAP-FLAG and c-Kit-WTor c-Kit-
D816V constructs. Cells were stimulated with SCF for 10 minutes where required and immediately lysed. Cell lysates were immunoprecipitated with an anti-FLAG
antibody and then processed for western blot analysis. (B) COS-1 cells were transfected with c-Kit-WTand SLAP-FLAG and/or empty vector. Cells were stimulated
with SCF for 10 minutes and processed for immunoprecipitation followed by western blotting. (C) COS-1 cells transfected with an equal amount of c-Kit-WT and
increasing amount of SLAP-FLAG. Cells were stimulated with SCF for 10 minutes and cell lysates were subjected to FLAG immunoprecipitation. Western blots from
two experiments with different concentrations of SLAP (relative SLAP expression, arbitrary units) and immunoprecipitated c-Kit (relative c-Kit amount that was pulled
down by SLAP-FLAG, arbitrary units) were quantified and plotted using GraphPad Prism 5.0. (D) Cell lysates from HMC1.2, TF-1 and P815 cells were
immunoprecipitatedwith an anti-SLAP antibody and then analyzed bywestern blotting. (E) Cell lysates fromTF-1 and P815 cells were immunoprecipitatedwith an anti-
SLAP antibody and then analyzed bywestern blotting. (F) Cell lysates fromHL60 cells stimulatedwith SCF or not were immunoprecipitated with an anti-SLAP antibody
and then analyzed by western blotting. (G) COS-1 cells were transfected with SLAP-FLAG and c-Kit-WTconstructs. Cells were stimulated with SCF for different times
followed by immunoprecipitation and western blotting analysis. The amount of c-Kit was quantified and the log value of the SCF stimulation time (min) was plotted
against the log value of the c-Kit amount. (H) COS-1 cells were transfected with c-Kit-WT and FLAG-tagged SLAP-WTor SLAP-R111E constructs. Cells were
stimulated with SCF or left unstimulated before lysis. Lysates were immunoprecipitated with an anti-FLAG antibody and then analyzed by western blotting. (I) COS-1
cells were transfected with SLAP-FLAG and c-Kit-WTor mutants. Cells were stimulated with SCF or left unstimulated before lysis. Lysates were immunoprecipitated
with an anti-FLAG antibody and then analyzed by western blotting. Relative binding was calculated by normalization against total pY-c-Kit.
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expression but was substantially affected by SLAP expression
(Fig. 1B,C) indicating that association is dependent on availability
of the SLAP protein. To explore endogenous binding, we checked
SLAP expression in the human mastocytoma HMC-1.2, human
erythroleukemia TF-1 and mouse mastocytoma P815 cell lines. The
TF-1 cell line endogenously expresses wild-type c-Kit, whereas both
HMC-1.2 and P815 cell lines express the oncogenic mutant, c-Kit-
D816V. We observed that the P815 cell line expresses higher levels
of SLAP than the other two cell lines (Fig. 1D). We then pulled-
down SLAP from P815 cell lysate using an anti-SLAP antibody. TF-
1 cell lysate was used as a negative control. We were able to detect c-
Kit-SLAP complexes in P815 cells (Fig. 1E). We were also able to
detect endogenous c-Kit and SLAP interaction in HL60 cells that
expressed wild-type c-Kit, and the interaction was ligand dependent
(Fig. 1F). In addition, c-Kit–SLAP interaction displayed a linear
decrease over the time but complexes were detectable until 4 hours
of SCF stimulation, suggesting that SLAP stably associates with
c-Kit (Fig. 1G).
SLAP associates with c-Kit through its SH2 domain at a site different
from the Src-binding site
SLAP associates only with the activated form of c-Kit suggesting
that the association is mediated through phosphotyrosine residues
of c-Kit and the SLAP SH2 domain. To test this hypothesis, we
generated the SLAP-R111E mutant in which the positively charged
crucial arginine residue in the phosphotyrosine binding pocket of
the SH2 domain was replaced with a negatively charged glutamic
acid. Thereby, this mutant has a negatively charged
phosphotyrosine binding pocket that will repulse phosphotyrosine
residues. We co-expressed c-Kit-WT and SLAP-WT-FLAG or
SLAP-R111E-FLAG in COS-1 cells. Although wild-type SLAP
efficiently pulled down c-Kit, the interaction was completely absent
when using the SLAP-SH2-domain-mutated form SLAP-R111E
(Fig. 1H), confirming that SLAP associates with c-Kit through its
SH2 domain. Because SLAP shares considerable structural
similarity with Src, we also checked whether SLAP associates
with c-Kit through the same tyrosine phosphorylation sites as Src.
For this purpose we used the c-Kit-Y568F, c-Kit-Y570F and c-Kit-
Y567F/Y570F mutants that fail to associate with Src. The results
indicated that this mutant of c-Kit is unable to block the association
with SLAP, although the binding was diminished because of the
lower total tyrosine phosphorylation of these mutants (Fig. 1I). We
therefore propose that SLAP associates with c-Kit through its SH2
domain and that the binding site is different from the one mediating
binding to the structurally related protein Src.
SLAP depletion increases c-Kit tyrosine phosphorylation
The association of adaptor proteins with the RTK proteins affects
receptor auto-phosphorylation (Lin et al., 2012). We transfected
COS-1 cells with increasing amounts of SLAP plasmid while
keeping the amount of c-Kit plasmid constant. Cells were serum-
starved overnight and stimulated with SCF for a fixed period of
time before lysis. We observed a linear decrease of c-Kit tyrosine
phosphorylation as well as c-Kit expression with increasing
SLAP expression but the net c-Kit tyrosine phosphorylation
remained unchanged (Fig. 2A). Because overexpression of
exogenous proteins can affect cellular behavior, we intended to
check the effect of SLAP on c-Kit phosphorylation using
endogenous proteins. Ba/F3 cells express a reasonable level of
SLAP but lack c-Kit expression (Kazi and Ro¨nnstrand, 2012).
Thus, we used Ba/F3 cells stably transfected with c-Kit (Ba/F3-c-
Kit cells) (Kazi et al., 2013b), and further stably transfected with
Fig. 2. SLAP depletion increases c-Kit phosphorylation. (A) COS-1 cells were transfected with c-Kit-WTand different amount of SLAP-FLAG and/or empty control
vector. Cells were stimulated for 5 minutes before lysis and subjected to immunoprecipitation and western blotting analysis. (B) Ba/F3 cells stably transfected with SLAP
shRNA or empty control vector were lysed and processed for immunoprecipitation with an anti-SLAP antibody followed by western blotting. (C) Ba/F3 c-Kit-WT-SLAP-
shRNA and Ba/F3-c-Kit-WT-control-shRNA were stimulated with SCF for different times before lysis. Lysates were processed for immunoprecipitation with an anti-c-Kit
antibody followed by western blotting. Blots from three experiments were quantified using Multi Gauge software. ns, not significant; **P,0.01.
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control shRNA vector (Ba/F3-c-Kit-control cells) or SLAP shRNA
vector (Ba/F3-c-Kit-SLAP-shRNA cells). We were able to achieve a
77.3% SLAP knockdown while keeping the c-Kit expression
unchanged (Fig. 2B). Ba/F3-c-Kit-control and Ba/F3-c-Kit-SLAP-
shRNA cells were stimulated with SCF for different periods of time
and then subjected to immunoprecipitation with an anti-c-Kit
antibody. Upon SLAP depletion c-Kit tyrosine phosphorylation was
significantly (P,0.01) increased (Fig. 2C) suggesting that SLAP is
required in order to maintain the normal level of receptor tyrosine
phosphorylation.
SLAP depletion decreases c-Kit ubiquitylation and degradation
SLAP association with FLT3 increases receptor ubiquitylation by
recruiting the Cbl E3 ubiquitin ligase to the receptor (Dragone et al.,
2006; Kazi and Ro¨nnstrand, 2012). We used Ba/F3-c-Kit-control and
Ba/F3-c-Kit-SLAP-shRNA cells to evaluate the effect of SLAP on c-Kit
ubiquitylation. Cells were serum-starved and treated with MG132 and
chloroquine diphosphate prior to SCF stimulation. We observed that
depletion of SLAP significantly (P,0.05) decreased c-Kit ubiquitylation
in response to SCF (Fig. 3A), which is in line with a previous finding
that SLAP potentiates ubiquitylation of RTKs (Dragone et al., 2006;
Kazi and Ro¨nnstrand, 2012). Because SLAP expression resulted in
increased ubiquitylation of c-Kit, we then tested whether increased
ubiquitylation leads to increased degradation of the receptor. We
observed that although SLAP expression significantly (P,0.001)
increased c-Kit degradation in COS-1 cells (Fig. 3B), SLAP depletion
significantly (P,0.05) stabilized c-Kit in Ba/F3 cells (Fig. 3C).
SLAP depletion increases SCF-induced Akt and Erk1/2
phosphorylation
SCF stimulation activates PI3K and MAPK pathways resulting in
phosphorylation of Akt, Erk1/2 and p38 (Lennartsson and Ro¨nnstrand,
2012; Masson and Ro¨nnstrand, 2009). To assess the role of SLAP in c-
Kit downstream signaling, we stimulated Ba/F3-c-Kit-control shRNA
and Ba/F3-c-Kit-SLAP-shRNA cells with SCF after 4 hours starvation.
SCF stimulation significantly (P,0.05) increased Akt phosphorylation
at 5 minutes (Fig. 4A). Erk1/2 phosphorylation was decreased at
2 minutes but increased at 5 minutes (Fig. 4B). Phosphorylation of p38
remained mostly unchanged (Fig. 4C). Furthermore, SCF stimulation
for an extended time period also had a similar effect on Akt (Fig. 4D)
and Erk1/2 (Fig. 4E) phosphorylation. Thus, we conclude that SLAP
negatively regulates SCF-induced c-Kit downstream signaling in a
selective manner.
SLAP controls Akt and Erk1/2 phosphorylation through SHC and
Gab2
Stimulation with SCF induces Akt and Erk1/2 phosphorylation
through several pathways. To understand which pathways are
affected by SLAP, we investigated the phosphorylation status of
SHC, SHP2 and Gab2. SHC phosphorylation was significantly
(P,0.05) decreased after 2 minutes of SCF stimulation whereas
it was increased after 5 minutes of SCF stimulation in SLAP-
depleted cells (Fig. 5A). SLAP depletion did not alter SHP2
phosphorylation (Fig. 5B) but enhanced Gab2 phosphorylation
after 5 minutes of SCF stimulation (Fig. 5C).
Fig. 3. SLAP depletion decreases c-Kit ubiquitylation and degradation. (A) Ba/F3-c-Kit-WT-SLAP-shRNA and Ba/F3-c-Kit-WT-control-shRNA cells were
stimulated with SCF for different times before lysis. Lysates were processed for immunoprecipitation with an anti-c-Kit antibody followed by western blotting.
Relative levels of ubiquitylation were then determined. (B) COS-1 cells were transfected with c-Kit-WT and different amount of SLAP or empty control vector.
Cells were incubated with cycloheximide for 30 minutes before 30 minutes of SCF stimulation. Then cells were lysed and lysates were processed for
immunoprecipitation with an anti-c-Kit antibody followed by western blotting. The percentage of c-Kit degradation was then determined. (C) Ba/F3-c-Kit-WT-
SLAP-shRNA and Ba/F3-c-Kit-WT-control-shRNA cells were incubated with cycloheximide for 30 minutes before 30 and 60 minutes of SCF stimulation.
Cells were then lysed and lysates were processed for immunoprecipitation with an anti-c-Kit antibody followed by western blotting. Blots from three experiments
were quantified using Multi Gauge software. ns, not significant; *P,0.05; **P,0.01; ***P,0.001.
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SLAP does not block c-Kit-D816V-induced Akt and Erk
phosphorylation
c-Kit and its oncogenic mutant c-Kit-D816V have different
effects in cellular signaling (Lennartsson et al., 2003; Sun et al.,
2009). Because SLAP associates with c-Kit-D816V, we
hypothesized that SLAP might negatively regulate c-Kit-D816V
signaling in a similar fashion to wild-type c-Kit. We transfected
wild-type SLAP or empty vector into the HMC-1.2 cells that
harbor the oncogenic mutant of c-Kit. Surprisingly, SLAP
expression did not block SCF-induced Akt and Erk1/2
phosphorylation (Fig. 6A). Similar results were obtained from
SLAP-depleted Ba/F3-c-Kit-D816V cells (Fig. 6B). Furthermore,
Fig. 4. SLAP depletion accelerates Akt and Erk1/2 phosphorylation. (A–E) Ba/F3-c-Kit-WT-SLAP-shRNA and Ba/F3-c-Kit-WT-control-shRNA cells were
serum starved for 4 hours before SCF stimulation for 0, 2 or 5 minutes (A–C) or 0, 5, 10 or 20 minutes (D,E). Cells were then lysed and lysates were subjected
for western blotting analysis using (A,D) anti-phospho-Akt, anti-Akt and anti-b-actin, (B,E) anti-phospho-Erk1/2, anti-Erk and anti-b-actin, and (C) anti-phospho-
p38, anti-p38 and anti-b-actin. Signal intensities were quantified using Multi Gauge software from three experiments. ns, not significant; *P,0.05.
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although SLAP depletion accelerated SCF-induced cell
proliferation, it did not affect c-Kit-D816V-induced cell
proliferation (Fig. 6C). Therefore, we suggest that SLAP
negatively regulates wild-type c-Kit signaling but not oncogenic
c-Kit-D816V signaling.
SLAP shows similar subcellular localization patterns with c-Kit-WT
and c-Kit-D816V
Because SLAP has different impacts on c-Kit signaling, we checked
whether this is due to the differential sub-cellular localization of SLAP.
We transfected COS-1 cells with SLAP-FLAG and c-Kit-WT or
c-Kit-D816V. Cells were serum-starved overnight and the
c-Kit-WT-transfected cells were stimulated with SCF before
paraformaldehyde fixation. Cells were then stained with Alexa-Fluor-
647-conjugated anti-FLAG (DYKDDDDK) and PE-conjugated c-Kit
antibodies. Subcellular localization was visualized with a laser scanning
confocalmicroscope. As expected SLAPwas found to be localized near
the inner surface of the cell membrane in both unstimulated (Fig. 7A)
and SCF-stimulated cells (Fig. 7B) as well as in c-Kit-D816V-
expressing cells (Fig. 7C). In addition, SCF stimulation and expression
of c-Kit-D816V significantly (P,0.05) increased colocalization of
SLAP with c-Kit, but colocalization of SLAP and c-Kit-WT or SLAP
and c-Kit-D816V were not affected (Fig. 7D).
Oncogenic c-Kit-D816V but not SCF stimulated wild-type c-Kit
induces SLAP tyrosine phosphorylation
To understand the mechanism of the differential regulation of
normal and oncogenic c-Kit signaling, we checked whether SLAP
was differentially modified by wild-type and oncogenic c-Kit. We
observed that only c-Kit-D816V but not wild-type c-Kit was able
to phosphorylate SLAP on tyrosine residues (Fig. 8A). Thus, we
suggest that SLAP-mediated differential regulation of c-Kit
downstream signaling might be due to the differential post-
translational modification of SLAP by oncogenic c-Kit.
Oncogenic c-Kit-D816V phosphorylates SLAP on residues Y120, Y258
and Y273
SLAP tyrosine phosphorylation sites have not been well studied.
The PhosphoSitePlus database (www.phosphosite.org) describes
three different predicted phosphorylation sites of SLAP in three
different species (Fig. 8B). To explore SLAP tyrosine phosphor-
ylation sites in living cells, we generated Y to F mutants of the
corresponding human SLAP tyrosine residues and observed that
mutation in any of those three sites reduced the total tyrosine
phosphorylation of SLAP, and that Y120 and Y258 sites are the
major tyrosine phosphorylation sites in SLAP phosphorylated by
c-Kit-D816V (Fig. 8C). Then we generated a SLAP-Y120F-
Y258F-Y273F (SLAP-YYYFFF) mutant to check whether SLAP
has any other minor tyrosine phosphorylation sites other than
those predicted. The triple mutant completely abolished c-Kit-
D816V-mediated tyrosine phosphorylation (Fig. 8D) of SLAP,
indicating the presence of only three tyrosine phosphorylation
sites (pY120, pY258 and pY273) in SLAP.
Association of SLAP with c-Kit-D816V is required for tyrosine
phosphorylation of SLAP
We then checked whether association of SLAP with c-Kit-D816V is
required for c-Kit-D816V-mediated tyrosine phosphorylation of
SLAP.We transfected cells with wild-type SLAP and non-functional
SH2 domain mutant SLAP-R111E together with c-Kit-D816V. We
observed that while c-Kit-D816V strongly phosphorylates wild-type
SLAP, SLAP-R111E remains mostly non-tyrosine-phosphorylated
(Fig. 8E) indicating that association of SLAP with c-Kit-D816V is
required for tyrosine phosphorylation of SLAP.
Fig. 5. SLAP depletion accelerates SHC and Gab2 phosphorylation. Ba/F3-c-Kit-WT-SLAP-shRNA and Ba/F3-c-Kit-WT-control-shRNA cells were serum
starved for 4 hours before SCF stimulation followed by lysis. (A) Cell lysates were immunoprecipitated with an anti-SHC antibody and then analyzed by
western blotting. (B) Cell lysates were subjected to western blotting analysis using anti-phospho-SHP2, anti-SHP2 and anti-b-actin. (C) Cell lysates were
subjected to western blotting analysis using anti-phospho-Gab2, anti-Gab2 and anti-b-actin. Signal intensities were quantified using Multi Gauge software from
three experiments. ns, not significant; *P,0.05.
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Mutation of the SLAP tyrosine phosphorylation sites rescues its
activity
Since we observed that c-Kit and its oncogenic counterpart c-Kit-
D816V differentially mediate SLAP tyrosine phosphorylation,
and SLAP differentially regulates wild-type and mutant c-Kit
signaling, we suggest that tyrosine phosphorylation of SLAP
inactivates SLAP. To verify this hypothesis we transfected wild-
type SLAP, SLAP-YYYFFF and empty vector into the HMC-1.2
cell line. We observed that SLAP-YYYFFF significantly (P,0.05)
decreased SCF-induced Akt and Erk1/2 phosphorylation (Fig. 9A,B)
suggesting that tyrosine phosphorylation of SLAP disrupts SLAP
activity. Single tyrosine mutants (SLAP-Y120F or -Y258F or
-Y273F) also exhibited similar reduction in phosphorylation
(Fig. 9C). These results are further supported by the observation
that expression of SLAP-YYYFFF but not SLAP-WT significantly
(P,0.05) decreased c-Kit-D816V-mediated cell growth (Fig. 9D).
DISCUSSION
Adaptor proteins control RTK signaling either by recruiting
ubiquitin ligases, phosphatases, kinases and other signaling
proteins, or competing with kinases or phosphatases for
association with receptors. Although the adaptor protein SLAP
negatively regulates RTK signaling by influencing degradation
and thereby reducing receptor turnover (Dragone et al., 2006;
Semerdjieva et al., 2013; Sosinowski et al., 2000), a couple of
reports suggest that SLAP propagates additional receptor
signaling through, as yet, poorly understood mechanisms (Kazi
and Ro¨nnstrand, 2012; Tang et al., 1999). In this report we show
Fig. 6. SLAP expression does not alter c-Kit-D816V-mediated
Akt or Erk1/2 phosphorylation. (A) HMC-1.2 cells transfected
with SLAP-WT or empty control vector were serum starved for
4 hours before SCF stimulation. Cells were then lysed and lysates
were processed for western blotting analysis using anti-phospho-
Akt, anti-Akt, anti-phospho-Erk1/2, anti-Erk, anti-SLAP and anti-b-
actin. (B) Ba/F3-c-Kit-D816V-SLAP-shRNA and Ba/F3-c-Kit-
D816V-control-shRNA cells were serum starved for 4 hours before
SCF stimulation. Cells were then lysed and lysates were subjected
for western blotting analysis using anti-phospho-Akt, anti-Akt, anti-
phospho-Erk1/2, anti-Erk and anti-b-actin. Signal intensities were
quantified using Multi Gauge software from three experiments. ns,
not significant; *P,0.05.
Fig. 7. SCF stimulation increases colocalization of SLAP with c-Kit. (A–C) COS-1 cells were co-transfected with SLAP-FLAG and c-Kit-WT or c-Kit-D816V
plasmids. Cells were serum starved overnight before stimulation and then fixed, permeabilized and stained with fluorophore-conjugated anti-FLAG antibody,
anti-c-Kit antibody and DAPI . Blue, DAPI; red, c-Kit; green, SLAP–FLAG. (D) Colocalization was quantified using CoLocalizer Pro 2.7.1. Pearson’s R-value was
used to measure colocalization of red and green colors from five cells. ns, not significant; *P,0.05.
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Fig. 8. c-Kit-D816V induces tyrosine phosphorylation of SLAP. (A) Cells were transfected with SLAP-FLAG and c-Kit-WT or c-Kit-D816V. Cells were
serum starved overnight before SCF stimulation. Cells were then lysed and lysates were immunoprecipitated with an anti-FLAG antibody and then analyzed by
western blotting. (B) Schematic showing the conserved tyrosine residues in human, mouse and rat. (C,D) Cells were transfected with FLAG-tagged SLAP
mutants and c-Kit-D816V. Cells were serum starved overnight before lysis and lysates were immunoprecipitated with an anti-FLAG antibody and analyzed by
western blotting. (E) Cells were transfected with c-Kit-D816V and FLAG-tagged SLAP-WT or SLAP-R111E mutant. Cells were serum starved overnight before
lysis. Lysates were immunoprecipitated with an anti-FLAG antibody and then analyzed by western blotting. pY-SLAP, tyrosine phosphorylated SLAP.
Fig. 9. SLAP mutant negatively
regulates c-Kit-D816V-mediated
Akt or Erk1/2 phosphorylation.
(A) HMC-1.2 cells transfected with
SLAP-WT, SLAP-YYYFFF or empty
control vector were serum starved for
4 hours before SCF stimulation.
Cells were then lysed and lysates
were processed for western blot
analysis. (B) Signal intensities from
three experiments were quantified
using Multi Gauge software.
(C) HMC-1.2 cells transfected with
SLAP-WT, SLAP-Y120F, SLAP-
Y258F, SLAP-Y273F or empty
control vector were serum starved for
4 hours before SCF stimulation.
Cells were then lysed and lysates
were processed for western blotting.
Signal intensities from three
experiments were quantified using
Multi Gauge software. (D) HMC-1.2
cells transfected with SLAP-WT,
SLAP-YYYFFF or empty control
vector were seeded in 96-well plates
and cultured for different time
periods. Cell viability measured
using PrestoBlue (Life Technologies)
assays according to the
manufacturer’s protocol. ns, not
significant; *P,0.05; **P,0.01.
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that SLAP plays dual roles in RTK signaling, depending on its
tyrosine phosphorylation status.
SLAP interacts with ligand stimulated c-Kit as well as with its
oncogenic form c-Kit-D816V. This association is mediated
through the SLAP SH2 domain and results in accelerated
ubiquitylation followed by receptor degradation. These findings
indicate that the c-Kit–SLAP interaction is dependent on c-Kit
tyrosine phosphorylation and that SLAP recruits ubiquitin ligases
which tag c-Kit for degradation. This is the most common
mechanism through which adaptor proteins regulate receptor
stability as well as downstream signaling (Dragone et al., 2006;
Dragone et al., 2009). Although, SLAP has a significant
(P,0.05) effect on c-Kit ubiquitylation, it is not the only factor
that regulates c-Kit stability. Several studies suggest that c-Kit
directly interacts with several ubiquitin ligases, such as Cbl
(Masson et al., 2006) and SOCS6 (Bayle et al., 2004), or through
indirect association of Cbl through Grb2 (Sun et al., 2007). Thus,
SCF-induced c-Kit degradation is controlled through a number of
different pathways and SLAP contributes to these pathways by
accelerating ubiquitylation.
Because SLAP accelerates receptor ubiquitylation followed by
degradation, it was expected that SLAP depletion would positively
regulate c-Kit downstream signaling. The fact that SLAP depletion
enhanced Akt, Erk1/2, SHC and Gab2 phosphorylation at
5 minutes partially supports the idea that this effect is mediated
through alteration of receptor stability, but early decrease of Erk1/2
or SHC phosphorylation and equal phosphorylation of p38 or
SHP2 cannot be explained by the same mechanism. Therefore, it is
of interest to identify how SLAP selectively controls c-Kit
signaling. Enhanced Akt, Erk1/2 phosphorylation also correlates
with increased receptor activation that was observed at 5 minutes
of SCF stimulation in SLAP-depleted cells. It is not clear why
SLAP depletion increases c-Kit tyrosine phosphorylation. One
possible explanation is that SLAP is regulating ubiquitylation
and degradation of another kinase that is involved in c-Kit
phosphorylation. Src family kinases (SFKs) promote c-Kit
tyrosine phosphorylation and SLAP is known to associate with
SFKs (Lennartsson et al., 2003; Sosinowski et al., 2000). Another
explanation could be that SLAP competes with SFKs for the same
binding site. However, we showed that SLAP does not associate
with the known Src-binding sites in c-Kit, so it is possible that other
SFKs associate with c-Kit through different tyrosine residues, which
overlaps with SLAP-binding sites. The non-receptor protein tyrosine
kinase Syk is another candidate (Tang et al., 1999). If there is a
depletion of SLAP, maybe more of the candidate tyrosine kinase
will bind to c-Kit and be activated, and this would then contribute to
c-Kit phosphorylation as well as downstream signaling. We know
from previous studies that other tyrosine kinases can associate with
and phosphorylate c-Kit (Lennartsson et al., 2003).
The inability of SLAP to elicit a negative regulation of c-Kit-
D816V-mediated signaling is probably due to the tyrosine
phosphorylation of SLAP, since the effect was restored in the
triple tyrosine mutant of SLAP. Because Cbl-N interacts with
SLAP through the C-terminus of SLAP and SLAP also forms
homodimers through its C-terminus (Tang et al., 1999), tyrosine
phosphorylation of SLAP in the C-terminus might disrupt
homodimerization as well as interaction with Cbl and thereby
disable the block of c-Kit-D816V-mediated signaling.
In conclusion we propose that SLAP negatively regulates
signal transduction events triggered by activated wild-type c-Kit.
In contrast, the oncogenic c-Kit-D816V form bypasses the
negative control of SLAP by phosphorylating SLAP on tyrosine
residues. Taken together, we demonstrate that an adaptor protein,
SLAP, is able to dramatically influence signaling downstream of
c-Kit despite the fact that it lacks enzymatic activity by itself.
MATERIALS AND METHODS
Plasmids, antibodies and reagents
The pcDNA3-c-Kit-WT, pcDNA3-c-Kit-D816V, pMSCV-c-Kit-WT,
pMSCV-c-Kit-D816V and pcDNA3-SLAP-WT plasmids were described
elsewhere (Kazi and Ro¨nnstrand, 2012; Kazi et al., 2013b). The pc-DNA3-
c-Kit-Y568F, pcDNA3-c-Kit-Y570F, pcDNA3-c-Kit-Y568F/Y570F, pcDNA3-
SLAP-Y120F, pcDNA3-SLAP-Y258F, pcDNA3-SLAP-Y273F, pcDNA3-
SLAP-Y120F/Y258/Y273F and pcDNA3-SLAP-R111E plasmids were
generated using the QuikChange site-directed mutagenesis kit (Stratagene).
All reagents and antibodies used in this study were described previously
(Kazi et al., 2013b).
Cell lines and culture conditions
COS-1 and P815 cells were cultured in DMEM supplemented with 10%
FBS. Ba/F3-c-Kit-WT and Ba/F3-c-Kit-D816V cells (Kazi et al., 2013b)
were cultured in RPMI 1640 medium supplemented with 10% FBS and
10 ng/ml recombinant murine IL-3, as recommended (Kazi et al., 2013a).
HMC-1.2 cells were cultured in Iscove’s Modified Dulbecco’s Medium
(IMDM) supplemented with 10% FBS. TF-1 cells were cultured in RPMI
1640 medium supplemented with 10% FBS and 10 ng/ml recombinant
human IL-3.
Electroporation, transient transfection and western blotting
Electroporation, transient transfection and western blotting methods were
described previously (Kazi and Ro¨nnstrand, 2012; Kazi et al., 2012; Kazi
et al., 2013b). For electroporation of HMC-1.2 cells, 4D-Nucleofector
(Lonza) was used. Cells were washed with PBS before electroporation in
serum-free solution (Lonza) using the DS104 program. Where statistical
analysis was applied, a minimum three replicates were used to calculate
mean value and standard error of the mean.
Confocal microscopy
Cells were fixed with 4% paraformaldehyde and then permeabilized and
blocked with a mixture of 0.5% Triton X-100 and 5% goat serum. Cells
were then stained with fluorophore-conjugated anti-c-KIT and anti-
FLAG antibodies for 1 hour. Nuclei were stained with DAPI before
mounting. Subcellular localization of c-Kit and SLAP–FLAG was
visualized with a Carl Zeiss LSM 710 laser scanning microscope.
CoLocalizer Pro 2.7.1 (www.colocalizer.com) was used to measure the
co-localization of green and red signals.
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